Procrysta Biologix Inc Natick, MA - 01760

Procrysta Biologix Inc is categorized under Commercial Medical Research in Natick, MA and active since 2009.

Procrysta Biologix Inc was established in 2009, and today employs 1 to 4, earning Unknown per year. This is a Commercial Medical Research business, which does work in the B2B market, and is classified as a Commercial Medical Research, under code number 5417113 by the NAICS.

If you are seeking more information, feel free to contact Saraswathi Mandapati, Marketing at the company’s single location by writing to 12 Michigan Drive, Natick, Massachusetts MA 01760 or by phoning (508) 318-6515. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Procrysta Biologix Inc
Contact Person: Saraswathi Mandapati, Marketing
Address: 12 Michigan Drive, Natick, Massachusetts 01760
Phone Number: (508) 318-6515
Website Address: procrysta.com
Annual Revenue (USD): Unknown
Founded: 2009
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2B (Business to Business)
Business Category: Commercial Medical Research
SIC Code: 8731
NAICS Code: 5417113
Share This Business:

Procrysta Biologix Inc was started in 2009 to provide professional Commercial Medical Research under the SIC code 8731 and NAICS code 5417113. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of Unknown per annum.

Feel free to contact Saraswathi Mandapati, Marketing for inquiries that concern Procrysta Biologix Inc by calling the company number (508) 318-6515, as your correspondence is most welcome. Additionally, the physical location of the single location of Procrysta Biologix Inc can be found at the coordinates 42.31353,-71.33512 as well as the street address 12 Michigan Drive in Natick, Massachusetts 01760.

For its online presence, you may visit Procrysta Biologix Inc’s website at procrysta.com and engage with its social media outlets through on Twitter and on Facebook.